Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real‐world data from the Swedish Heart Failure Registry

BACKGROUND: Randomized controlled trials (RCT) generalizability may be limited due to strict patient selection. OBJECTIVE: In a real‐world heart failure (HF) population, we assessed eligibility for sacubitril/valsartan based on PARADIGM‐HF (sacubitril/valsartan effective)/PARAGON‐HF [sacubitril/vals...

Descripción completa

Detalles Bibliográficos
Autores principales: Savarese, G., Hage, C., Benson, L., Schrage, B., Thorvaldsen, T., Lundberg, A., Fudim, M., Linde, C., Dahlström, U., Rosano, G. M. C., Lund, L. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984286/
https://www.ncbi.nlm.nih.gov/pubmed/32776357
http://dx.doi.org/10.1111/joim.13165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984286/
https://www.ncbi.nlm.nih.gov/pubmed/32776357
http://dx.doi.org/10.1111/joim.13165

Ejemplares similares